The 87 rating InvestorsObserver gives to Mirum Pharmaceuticals Inc (MIRM) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 98 percent of stocks in the Biotechnology industry, MIRM’s 87 overall rating means the stock scores better than 87 percent of all stocks.
MIRM has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on MIRM!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Mirum Pharmaceuticals Inc Stock Today?
Mirum Pharmaceuticals Inc (MIRM) stock has gained 0.93% while the S&P 500 is lower by -0.38% as of 11:14 AM on Tuesday, Nov 21. MIRM is up $0.30 from the previous closing price of $32.10 on volume of 95,614 shares. Over the past year the S&P 500 has risen 14.69% while MIRM is up 68.14%. MIRM lost -$4.30 per share the over the last 12 months.
Click Here to get the full Stock Report for Mirum Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
